Brief: Bill & Melinda Gates Foundation Reports 15.8% Stake In Lumiradx Ltd As Of July 25, 2022 - SEC Filing
03/08/2022 22:54
Aug 3 (Reuters) - LumiraDx Ltd LMDX.O :
* BILL & MELINDA GATES FOUNDATION REPORTS 15.8% STAKE IN
LUMIRADX
LTD AS OF JULY 25, 2022 - SEC FILING
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing